Matthew A. Spear

1.9k total citations
59 papers, 1.2k citations indexed

About

Matthew A. Spear is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Matthew A. Spear has authored 59 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 23 papers in Oncology and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Matthew A. Spear's work include Ubiquitin and proteasome pathways (14 papers), Multiple Myeloma Research and Treatments (9 papers) and Virus-based gene therapy research (8 papers). Matthew A. Spear is often cited by papers focused on Ubiquitin and proteasome pathways (14 papers), Multiple Myeloma Research and Treatments (9 papers) and Virus-based gene therapy research (8 papers). Matthew A. Spear collaborates with scholars based in United States, Australia and Estonia. Matthew A. Spear's co-authors include G. Kenneth Lloyd, Ira J. Spiro, Herman D. Suit, Andrew E. Rosenberg, Henry J. Mankin, James T. Efird, L. Candace Jennings, Mark C. Gebhardt, Alain C. Mita and Xandra O. Breakefield and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Matthew A. Spear

58 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew A. Spear United States 18 629 459 225 225 215 59 1.2k
Susan C. Weil United States 21 464 0.7× 503 1.1× 249 1.1× 105 0.5× 79 0.4× 53 1.4k
James B. Smadbeck United States 21 602 1.0× 235 0.5× 173 0.8× 196 0.9× 80 0.4× 74 1.2k
Magdalena Martinka Canada 26 1.2k 2.0× 728 1.6× 136 0.6× 97 0.4× 142 0.7× 62 2.3k
Dario Sangiolo Italy 25 549 0.9× 1.4k 3.0× 442 2.0× 139 0.6× 69 0.3× 76 2.2k
Mariana Nacht United States 17 1.0k 1.6× 441 1.0× 133 0.6× 90 0.4× 25 0.1× 27 1.5k
A Peng China 9 896 1.4× 338 0.7× 162 0.7× 34 0.2× 124 0.6× 12 1.4k
E B Bröcker Germany 19 653 1.0× 442 1.0× 45 0.2× 75 0.3× 196 0.9× 27 1.5k
Anne Estreicher Switzerland 15 756 1.2× 537 1.2× 95 0.4× 332 1.5× 27 0.1× 24 1.6k
Ann Cleverly United States 25 1.3k 2.1× 1.5k 3.3× 333 1.5× 94 0.4× 45 0.2× 54 2.6k
Roland Grenningloh United States 22 414 0.7× 259 0.6× 48 0.2× 164 0.7× 123 0.6× 39 1.4k

Countries citing papers authored by Matthew A. Spear

Since Specialization
Citations

This map shows the geographic impact of Matthew A. Spear's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew A. Spear with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew A. Spear more than expected).

Fields of papers citing papers by Matthew A. Spear

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew A. Spear. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew A. Spear. The network helps show where Matthew A. Spear may publish in the future.

Co-authorship network of co-authors of Matthew A. Spear

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew A. Spear. A scholar is included among the top collaborators of Matthew A. Spear based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew A. Spear. Matthew A. Spear is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, G., Matthew A. Spear, Larry Alphs, et al.. (2025). ANK3 as a Novel Genetic Biomarker for Liafensine in Treatment-Resistant Depression. JAMA Psychiatry. 82(12). 1186–1186. 1 indexed citations
2.
Costello, Caitlin, Tara Gregory, Syed Abbas Ali, et al.. (2019). Phase 2 Study of the Response and Safety of P-Bcma-101 CAR-T Cells in Patients with Relapsed/Refractory (r/r) Multiple Myeloma (MM) (PRIME). Blood. 134(Supplement_1). 3184–3184. 43 indexed citations
3.
Millward, Michael, Paul N. Mainwaring, Alain C. Mita, et al.. (2011). Phase 1 study of the novel vascular disrupting agent plinabulin (NPI-2358) and docetaxel. Investigational New Drugs. 30(3). 1065–1073. 66 indexed citations
4.
Spear, Matthew A., Patricia LoRusso, Alain C. Mita, & Monica Mita. (2011). Vascular Disrupting Agents (VDA) in Oncology: Advancing Towards New Therapeutic Paradigms in the Clinic. Current Drug Targets. 12(14). 2009–2015. 27 indexed citations
5.
6.
Wang, Zheng, Zhaohui Tang, Yuhua Zheng, et al.. (2010). Development of a nonintegrating Rev-dependent lentiviral vector carrying diphtheria toxin A chain and human TRAF6 to target HIV reservoirs. Gene Therapy. 17(9). 1063–1076. 18 indexed citations
7.
LoRusso, Patricia, Lorrin Yee, K. Papadopoulos, et al.. (2007). Phase 1 clinical trials of NPI-2358 (a novel vascular disrupting agent) in patients with solid tumors and lymphomas. Molecular Cancer Therapeutics. 6. 1 indexed citations
8.
McClay, Edward F., et al.. (2007). Phase I/II study of IV topotecan in combination with whole brain radiation for the treatment of brain metastases. Medical Oncology. 24(2). 147–153. 4 indexed citations
9.
Spear, Matthew A., Patricia LoRusso, A. W. Tolcher, et al.. (2007). A phase 1 dynamic accelerated titration dose escalation study of the vascular disrupting agent NPI-2358. Journal of Clinical Oncology. 25(18_suppl). 14097–14097. 2 indexed citations
10.
Bahl, Gautam, et al.. (2006). Focal Radiation Therapy of Brain Metastases After Complete Surgical Resection. Medical Oncology. 23(3). 317–324. 9 indexed citations
11.
Grandi, Paola, Samuel Wang, Deborah E. Schuback, et al.. (2004). HSV-1 Virions Engineered for Specific Binding to Cell Surface Receptors. Molecular Therapy. 9(3). 419–427. 35 indexed citations
12.
Spear, Matthew A., et al.. (2004). Phase I/II trial of IV topotecan (TOPO) in combination with whole brain radiation therapy (WBXRT). Journal of Clinical Oncology. 22(14_suppl). 1553–1553. 1 indexed citations
13.
Spear, Matthew A., Deborah E. Schuback, Kenichi Miyata, et al.. (2003). HSV-1 amplicon peptide display vector. Journal of Virological Methods. 107(1). 71–79. 12 indexed citations
14.
Spear, Matthew A., Xandra O. Breakefield, James Beltzer, et al.. (2001). Isolation, characterization, and recovery of small peptide phage display epitopes selected against viable malignant glioma cells. Cancer Gene Therapy. 8(7). 506–511. 33 indexed citations
15.
Spear, Matthew A., Fang Sun, Elizabeth A. Gilpin, et al.. (2000). Cytotoxicity, apoptosis, and viral replication in tumor cells treated with oncolytic ribonucleotide reductase-defective herpes simplex type 1 virus (hrR3) combined with ionizing radiation. Cancer Gene Therapy. 7(7). 1051–1059. 40 indexed citations
16.
Spear, Matthew A., et al.. (1999). Tolerance of autologous and allogeneic bone grafts to therapeutic radiation in humans. International Journal of Radiation Oncology*Biology*Physics. 45(5). 1275–1280. 6 indexed citations
17.
Schellingerhout, Dawid, Alexei Bogdanov, E Marecos, et al.. (1998). Mapping the In Vivo Distribution of Herpes Simplex Virions. Human Gene Therapy. 9(11). 1543–1549. 54 indexed citations
18.
Spear, Matthew A., Ulrich Herrlinger, Nikolai G. Rainov, et al.. (1998). Targeting gene therapy vectors to CNS malignancies. Journal of NeuroVirology. 4(2). 133–147. 21 indexed citations
19.
Spear, Matthew A., L. Candace Jennings, Henry J. Mankin, et al.. (1998). Individualizing management of aggressive fibromatoses. International Journal of Radiation Oncology*Biology*Physics. 40(3). 637–645. 214 indexed citations
20.
Suit, Herman D., Ira J. Spiro, & Matthew A. Spear. (1997). Benign and low-grade tumors of the soft tissues: Role for radiation therapy. Cancer treatment and research. 91. 95–105. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susan C. Weil Breakdown of academic impact, for papers by James B. Smadbeck Breakdown of academic impact, for papers by Magdalena Martinka Breakdown of academic impact, for papers by Dario Sangiolo Breakdown of academic impact, for papers by Mariana Nacht Breakdown of academic impact, for papers by A Peng Breakdown of academic impact, for papers by E B Bröcker Breakdown of academic impact, for papers by Anne Estreicher Breakdown of academic impact, for papers by Ann Cleverly Breakdown of academic impact, for papers by Roland Grenningloh
Rankless by CCL
2026